Department of Urology, IRCCS "Regina Elena" National Cancer Institute, 00128 Rome, Italy.
Sensors (Basel). 2023 Aug 11;23(16):7104. doi: 10.3390/s23167104.
The advent of robotic surgical systems had a significant impact on every surgical area, especially urology, gynecology, and general and cardiac surgery. The aim of this article is to delineate robotic surgery, particularly focusing on its historical background, its evolution, its present status, and its future perspectives. A comprehensive literature review was conducted upon PubMed/MEDLINE, using the keywords "robotic surgical system", "robotic surgical device", "robotics AND urology". Additionally, the retrieved articles' reference lists were investigated. Analysis concentrated on urological surgical systems for laparoscopic surgery that have been given regulatory approval for use on humans. From the late 1980s, before Era in 2000s, ancestor platform as Probot and PUMA 560 were described to outline historical perspective. Thus, new robotic competitors of Intuitive Surgical such as , , , , , and were illustrated. Although had high level competitiveness, and for many years represented the most plausible option for robotic procedures, several modern platforms are emerging in the surgical market. Growing competition through unique features of the new robotic technologies might extend applications fields, improve diffusion, and increase cost-effectiveness procedures. More experiences are needed to identify the role of these new advancements in surgical branches and in healthcare systems.
机器人手术系统的出现对每个外科领域都产生了重大影响,特别是泌尿科、妇产科以及普通外科和心脏外科。本文旨在描述机器人手术,特别是其历史背景、发展、现状和未来展望。我们在 PubMed/MEDLINE 上使用了“机器人手术系统”、“机器人手术设备”、“机器人和泌尿科”等关键词进行了全面的文献回顾。此外,还对检索到的文章的参考文献进行了研究。分析集中在已获得监管机构批准用于人体的腹腔镜手术的泌尿科机器人手术系统上。从 20 世纪 80 年代末到 21 世纪初的 时代,描述了祖先平台如 Probot 和 PUMA 560 以勾勒出历史视角。因此,介绍了直觉外科(Intuitive Surgical)等新的机器人竞争对手,如 Da Vinci、Xi、Zeus、Versius、Hugo 和 Monarch。虽然 具有很高的竞争力,并且多年来一直是机器人手术的最合理选择,但许多新的手术平台正在外科市场上出现。新的机器人技术的独特功能带来的竞争可能会扩大应用领域、提高普及程度并提高成本效益的手术。需要更多的经验来确定这些新进展在外科分支和医疗保健系统中的作用。